PMA device
Oxford Unicompartmental Knee System
Biomet Manufacturing Corp · Prosthesis, Knee, Femorotibial, Unicompartmental, Semi-Constrained, Metal/Polymer, Mobile Bearing (NRA, Class III) · First FDA decision Aug 5, 2011, newest Aug 5, 2011Knee osteoarthritis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
36
Naming "Oxford"
MAUDE reports
3,127
Brand "Oxford", since 2015
PubMed studies
25,576
Mentioning "Oxford"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Oxford Unicompartmental Knee System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- OXFORD UNICOMPARTMENTAL KNEE SYSTEMPMA supplement
P010014-S014 · Decided Aug 5, 2011 · 1,683 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, knee, femorotibial, unicompartmental, semi-constrained, metal/polymer, mobile bearing (NRA) · Orthopedic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Oxford", any status and sponsor, newest update first.
University of SalfordAcademic, hospital or other
NCT07685496 · 15 participants (planned) · Start Nov 3, 2026 · Primary completion Dec 15, 2026
Device: Own Footwear; Oxford Shoe and 2 more · For: Transtibial Amputation; Lower Limb Amputation; Prosthesis Users
Sites: Manchester, United Kingdom
- VRehab-SMA Phase 1.2Active, not recruiting
University of OxfordAcademic, hospital or other
NCT07578454 · 12 participants (planned) · Start May 27, 2026 · Primary completion Apr 2027
Device: VRehab SMA device · For: Spinal Muscular Atrophy (SMA)
Sites: Oxford, United Kingdom
Universitas PadjadjaranAcademic, hospital or other
NCT07817784 · 75 participants (planned) · Start Sep 1, 2026 · Primary completion Oct 1, 2026
Device: OCS Plus Assessment · For: Post Stroke; Cognitive Assessment
33 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Oxford", and for the whole product code for context.
This brand
3,127 reports: 259 malfunction, 2,839 injury, 28 death
Whole product code NRA
4,438 reports: 183 malfunction, 4,196 injury, 58 death
Newest reports for this brand
- OXFORD FEMORAL SLAP HAMMERMalfunction
3002806535-2026-00378 · Received Oct 22, 2026 · Event dated Sep 29, 2026
Device type: Orthopedic Manual Surgical Instrument (LXH)
Device problem as coded: Fracture
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3002806535-2026-00369 · Received Oct 16, 2026 · Event dated Sep 21, 2026
Device type: Prosthesis, Knee, Femorotibial, Unicompartmental, Semi-Constrained, Metal/Polymer, Mobile Bearing (NRA)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: Arthritis; Pain; Loss of Range of Motion; Joint Dislocation; Ambulation or Postural Difficulties; Joint effusion
3002806535-2026-00370 · Received Oct 16, 2026 · Event dated Sep 21, 2026
Device type: Prosthesis, Knee, Femorotibial, Unicompartmental, Semi-Constrained, Metal/Polymer, Mobile Bearing (NRA)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Arthritis; Pain; Loss of Range of Motion; Joint Dislocation; Ambulation or Postural Difficulties; Joint effusion
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1152-2017 · Started Jan 5, 2016
Reason given: Zimmer Biomet is conducting a medical device field action for various lot-specific Oxford Knee instruments due to potential alumina inclusions in the raw material batch used to produce the affected products. Inclusions contained within the finished product could lead to the cracking and separation of the instrument.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Orthopedic Manual Surgical Instrument (LXH)
Z-1153-2017 · Started Jan 5, 2016
Reason given: Zimmer Biomet is conducting a medical device field action for various lot-specific Oxford Knee instruments due to potential alumina inclusions in the raw material batch used to produce the affected products. Inclusions contained within the finished product could lead to the cracking and separation of the instrument.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Orthopedic Manual Surgical Instrument (LXH)
Z-1154-2017 · Started Jan 5, 2016
Reason given: Zimmer Biomet is conducting a medical device field action for various lot-specific Oxford Knee instruments due to potential alumina inclusions in the raw material batch used to produce the affected products. Inclusions contained within the finished product could lead to the cracking and separation of the instrument.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Driver, Prosthesis (HWR)
19 more recall records with a free account
Published research
The most relevant PubMed records for "Oxford"[tiab]. The summary above synthesizes these.
- Introducing Oxford Open Neuroscience.
Gilbert S, Ibáñez C, Izquierdo A, et al. · Oxf Open Neurosci · 2022Editorial
- The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community.
Jain M, Olsen HE, Paten B, et al. · Genome Biol · 2016Research Support, N.I.H., Extramural
- Long-Read Single-Cell Sequencing Using scCOLOR-seq.
Philpott M, Oppermann U, Cribbs AP · Methods Mol Biol · 2023Research Support, Non-U.S. Gov't
- The risk of biological race.
Neto C · Hist Philos Life Sci · 2025
- One-dimensional Lieb-Oxford bounds.
Laestadius A, Faulstich FM · J Chem Phys · 2020
- Family values.
Brooks DR · Trends Ecol Evol · 1998
- Oxford Nanopore bests PacBio.
Nat Biotechnol · 2019News
- In conversation with Xin Lu.
Howe FS, Lu X · FEBS J · 2020Interview
- Oxford's tumour marker.
Lancet · 1982Editorial
- Oxford University.
Hospital (Lond 1886) · 1913
- Oxford University.
Hospital (Lond 1886) · 1912
- Oxford University.
Hospital (Lond 1886) · 1911
Other devices of this type
Also filed under product code NRA.
- Oxford Partial Knee SystemBiomet Manufacturing Corp · PMA 2026
- Oxford Meniscal Unicompartmental Knee SystemBiomet Manufacturing Corp · PMA 2013
- Oxford Cementless Partial Knee SystemBiomet Manufacturing Corp · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.